Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription

Articles published in
Rev Neurol
    May 2022
  1. LAFUENTE-GOMEZ G, Anaya-Fernandez Lomana F, Gomez-Roldos A, Garcia-Dominguez JM, et al
    [Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report].
    Rev Neurol. 2022;74:340-342.
    >> Share

    April 2022
  2. GARCIA-ESTEVEZ DA, Perez-Lorenzo G, Fernandez-Perez MJ, Cid-Rodriguez C, et al
    [Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis].
    Rev Neurol. 2022;74:265-268.
    >> Share

    October 2021
  3. ZABAY-NEIRO MC, Nieves-Collado M, Carres-Gonzalez G, Curto-Estupina G, et al
    [Evaluation of the impact of lockdown on the health and lifestyle of users of the Fundacio Esclerosi Multiple's neurorehabilitation centres in Lleida and Reus].
    Rev Neurol. 2021;73:249-257.
    >> Share

    September 2021
  4. MIDAGLIA L, Sastre-Garriga J, Montalban X
    [Clinical monitoring of multiple sclerosis patients by means of digital technology, a field in the midst of a revolution].
    Rev Neurol. 2021;73:210-218.
    >> Share

    August 2021
  5. MECA-LALLANA V, Rodriguez-Antiguedad A, Llaneza MA, Meca-Lallana JE, et al
    [Plasma determination of neurofilaments as biomarkers in multiple sclerosis: conclusions of the EMotion Forum].
    Rev Neurol. 2021;73:101-110.
    >> Share

    June 2021
  6. FERNANDEZ O, Montalban X, Aladro Y, Alonso A, et al
    13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (II).
    Rev Neurol. 2021;72:433-442.
    >> Share

  7. FERNANDEZ O, Montalban X, Aladro Y, Alonso A, et al
    13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I).
    Rev Neurol. 2021;72:397-406.
    >> Share

    April 2021
  8. COSTA FROSSARD-FRANCA L, Garcia-Dominguez JM, Moreno-Torres I, Fortun J, et al
    [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Rev Neurol. 2021;72:250-260.
    >> Share

    March 2021
  9. BENITO-VILLALVILLA D, Lopez de Uralde-Villanueva I, Rios-Leon M, Alvarez-Melcon AC, et al
    [Effectiveness of motor imagery in patients with multiple sclerosis: a systematic review].
    Rev Neurol. 2021;72:157-167.
    >> Share

    January 2021
  10. CRISTIANO E, Patrucco L, Ysrraelit MC, Alonso R, et al
    [Argentinean consensus guidelines on the identification and clinical care of secondary progressive multiple sclerosis].
    Rev Neurol. 2021;72:23-32.
    >> Share

    August 2020
  11. CARDENAS-ROBLEDO S, Otero-Romero S, Montalban X, Tintore M, et al
    [Prevalence and impact of comorbidities in patients with multiple sclerosis].
    Rev Neurol. 2020;71:151-158.
    >> Share

    July 2020
  12. GARCIA-ESTEVEZ DA, Fraga-Gonzalez C, Ramos-Pacho ME, Lopez-Diaz LM, et al
    [The prevalence of multiple sclerosis in the city of Ourense, Galicia, in the north-west of the Iberian Peninsula].
    Rev Neurol. 2020;71:19-25.
    >> Share

    May 2020
  13. COSTA-FROSSARD L, Moreno-Torres I, Meca-Lallana V, Garcia-Dominguez JM, et al
    [EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic].
    Rev Neurol. 2020;70:329-340.
    >> Share

    January 2020
  14. JIMENEZ-ZAMBRANO J, Zambrano-Llaguno K, Acuna-Chong MG
    Social anxiety disorder among patients with multiple sclerosis: a population-based case-control study in Ecuador.
    Rev Neurol. 2020;70:45-52.
    >> Share

    December 2019
  15. OREJA-GUEVARA C, Garcia-Merino JA, Saiz A, Rodriguez-Antiguedad A, et al
    [Recommendations for the use of cladribine tablets in recurring multiple sclerosis].
    Rev Neurol. 2019;69.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016